Marie-louise Uhre Hansen

Dr. Marie-louise Uhre Hansen

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Journal of Infection
Verified
Journal Article
Closed access
NGN. Gotland
N. Gotland
MHMarie-louise Uhre Hansen
Marie-louise Uhre Hansen
NMN. Mejer
N. Mejer
RSR. Skov
R. Skov
APA. Petersen
A. Petersen
TBThomas Benfield
Thomas Benfield

8 May 2014 in Medicine, Science and the Law
Verified
Journal Article
Closed access
MHMarie-louise Uhre Hansen
Marie-louise Uhre Hansen
AEAnne Marie Eriksen
Anne Marie Eriksen
KSKim Pilkjær Simonsen
Kim Pilkjær Simonsen
ARArne Redsted Rasmussen
Arne Redsted Rasmussen
BHBenjamin Benn Hjort
Benjamin Benn Hjort
NLNiels Lynnerup
Niels Lynnerup
This proof of concept study investigates the removal of soft tissue from human ribs with the use of two common methods: boiling with a laundry detergent and using enzymes. Six individuals were autopsied, and one rib from each individual was removed for testing. Each rib was cut into pieces and afterwards macerated by one of the two methods. DNA extraction was performed to see the effect of the macerations on DNA preservation. Furthermore, the bone pieces were examined in a stereomicroscope to assess for any bone damage. The results demonstrated that both methods removed all flesh/soft tissue from the bones. The DNA analysis showed that DNA was preserved on all the pieces of bones which were examined. Finally, the investigation suggests that enzyme maceration could be gentler on the bones, as the edges appeared less frayed. The enzyme maceration was also a quicker method; it took three hours compared with the traditional method which took about 24 hours. However, a more standardised study should be performed to confirm this.

23 May 2017 in Infectious Diseases
Verified
Journal Article
Closed access
MHMarie-louise Uhre Hansen
Marie-louise Uhre Hansen
NGNanja Gotland
Nanja Gotland
NMNiels Mejer
Niels Mejer
APAndreas Petersen
Andreas Petersen
ALAnders R. Larsen
Anders R. Larsen
FGfor the Danish Staphylococcal Bacteremia Study Group
for the Danish Staphylococcal Bacteremia Study Group
Background: This study investigated the effect and influence of diabetes severity on susceptibility and 30-day mortality of Staphylococcus aureus bacteremia (SAB). Methods: Nationwide population-based study of individuals with SAB and matched population controls. Diabetes severity was categorized based on International Classification of Diseases codes and the odds ratio (OR) with 95% confidence intervals (CI) of SAB associated with diabetes was estimated by conditional logistic regression analysis. Hazard ratios (HR) were analyzed by Cox proportional regression. Analyses were adjusted for age, sex, comorbidity, hospital contact and diabetes duration. Results: Of 25,855 SAB cases, 2797 (10.8%) had diabetes and 2913 (11.3%) had diabetes with complications compared to 14,189 (5.5%) and 5499 (2.1%) of 258,547 controls. This corresponded to an increased risk of SAB associated with diabetes without complications (OR 1.83 (95% CI 1.74–1.92)) and of diabetes with complications (OR 3.62 (95% CI 3.43–3.81) compared to no diabetes. The risk of SAB was highest within the first year of diabetes. Diabetes without complications was associated with an increased risk of 30-day mortality (HR 1.62 (95% CI 1.01–2.60)) compared to no diabetes. Diabetes with complications was overall not associated with increased 30-d mortality (HR 1.36 (95% CI 0.84–2.20)) except for individuals with ketoacidosis/coma (HR 2.01 (95% 1.17–3.45)). Conclusions: Diabetes, particularly, diabetes with complications significantly increased the risk of SAB. In contrast, there was an increased risk of 30-day mortality after SAB for diabetes without complications but not for diabetes with complications overall. Diabetes with ketoacidosis/coma conferred the highest relative risk of 30-day mortality.

29 September 2023 in Endocrine-Related Cancer
Verified
Journal Article
Closed access
PDF file
WZWalid Zeyghami
Walid Zeyghami
MHMarie-louise Uhre Hansen
Marie-louise Uhre Hansen
KJKathrine Kronberg Jakobsen
Kathrine Kronberg Jakobsen
CGChristian Groenhøj
Christian Groenhøj
UFUlla Feldt-Rasmussen
Ulla Feldt-Rasmussen
CHChristoffer Holst Hahn
Christoffer Holst Hahn
Thyroid cancer (TC) represents the most common endocrine malignant tumor. Liquid biopsy has been suggested as a new and accurate biomarker in cancer. This systematic review analyzes the existing literature on circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA integrity index (cfDI), and their potential as biomarkers for TC, including the subtypes: differentiated (papillary and follicular), medullary, and anaplastic. A systematic search was performed in PubMed, Embase, and Cochrane databases for published articles in English between 1 January 1970 and 6 September 2022 (PROSPERO: CRD42022358592). The literature search generated a total of 635 articles. In total, 36 articles were included (patients = 2566). Four studies reported that higher levels of CTCs were associated with metastases and worse prognosis. Nineteen studies found the presence of mutated ctDNA in TC patients. The diagnostic accuracy in detecting BRAFV600E as ctDNA was determined in 11 studies regarding papillary TC. The pooled sensitivity, specificity, and diagnostic odds ratio were estimated at 56% (95% CI 36–74), 91% (95% CI 84–95) and 12 (95% CI 4.09–33.11), respectively. Four studies concluded that the cfDI was higher in patients with TC compared to benign thyroid lesions and healthy controls. The detection of CTCs, ctDNA, and cfDI may have a potential prognostic value in TC in relation to diagnosis, disease progression, and treatment efficacy. Despite the promising potential of CTCs, ctDNA, and cfDI in TC management, limitations hinder direct comparison and generalization of findings. Standardized methodologies, larger patient cohorts, and a consensus on relevant markers are needed to validate their clinical applicability and enhance TC management.

1 August 2015 in Journal of Infection
Verified
Journal Article
Closed access
NMN. Mejer
N. Mejer
NGN. Gotland
N. Gotland
MHMarie-louise Uhre Hansen
Marie-louise Uhre Hansen
HWHenrik Westh
Henrik Westh
HSH.C. Schønheyder
H.C. Schønheyder
TBThomas Benfield
Thomas Benfield

18 November 2022 in Ear & Hearing
Verified
Journal Article
Closed access
MHMarie-louise Uhre Hansen
Marie-louise Uhre Hansen
EREva Rye Rasmussen
Eva Rye Rasmussen
PCPer Cayé-Thomasen
Per Cayé-Thomasen
KMKristianna Mey
Kristianna Mey
Objectives: This study investigated age at implantation, improvement in hearing and speech perception outcomes, as well as surgical complications in pediatric cochlear implant recipients with Pendred Syndrome (PS) or non-syndromic enlarged vestibular aqueduct (NSEVA). Design: A systematic review of the literature between 1984 and 2021 was performed. Two independent reviewers performed abstract and full-text screening using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. The inclusion criteria were: English language, cochlear implant, age at implantation available, age <18 years, PS, Mondini malformation, and enlarged vestibular aqueduct. Full-text analysis was completed using the National Institute of Health assessment tool for case series and case-control studies. Studies were also graded according to the Oxford Centre for Evidence-Based Medicine grading system. Results: In total, 198 studies were identified and screened, and 55 studies were included for analysis. Audiological outcomes were available in 46 studies, and the four-frequency pure-tone audiogram average improved by 60 to 78 dB HL due to cochlear implantation. Auditory performance and speech intelligibility scores increased by 44%. The overall average implantation age was 60 months. The implantation age was 21 months lower in the studies where individuals were implanted after the year 2000 compared with those implanted before the year 2000. Perilymph gusher/oozing was the most common surgical incident reported, occurring in 187 of 1572 implantations. Conclusions: In children with PS/NSEVA, cochlear implantation improves pure-tone average by 60 to 78 dB HL and capacity of auditory performance/speech intelligibility by 44%. The implantation age for these children has decreased during the last two decades but is still somewhat higher than reported for unselected pediatric cochlear implantation. Perilymph gusher/oozing is the most common surgical complication.